[
  {
    "ts": "2025-11-17T01:11:50+00:00",
    "headline": "How the Narrative Around Eli Lilly Is Evolving After New Analyst Updates and Drug Developments",
    "summary": "Eli Lilly's stock has captured attention as consensus analyst price targets have risen from $919 to $1,003 per share. This shift underscores renewed optimism about the company's valuation prospects. The upward revision largely reflects analysts’ growing confidence in revenue growth, supported by robust demand for key treatments and steady execution across major franchises. As Wall Street continues to update its outlook in response to new data and market dynamics, readers will want to keep an...",
    "url": "https://finance.yahoo.com/news/narrative-around-eli-lilly-evolving-011150649.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "29d1cb09-407d-3d79-8d01-63cd5b70f840",
      "content": {
        "id": "29d1cb09-407d-3d79-8d01-63cd5b70f840",
        "contentType": "STORY",
        "title": "How the Narrative Around Eli Lilly Is Evolving After New Analyst Updates and Drug Developments",
        "description": "",
        "summary": "Eli Lilly's stock has captured attention as consensus analyst price targets have risen from $919 to $1,003 per share. This shift underscores renewed optimism about the company's valuation prospects. The upward revision largely reflects analysts’ growing confidence in revenue growth, supported by robust demand for key treatments and steady execution across major franchises. As Wall Street continues to update its outlook in response to new data and market dynamics, readers will want to keep an...",
        "pubDate": "2025-11-17T01:11:50Z",
        "displayTime": "2025-11-17T01:11:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uZWvuDuy6_Wr6cKvxAFZcw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g78F5NO5pySOmBHzFi6.eA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/narrative-around-eli-lilly-evolving-011150649.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/narrative-around-eli-lilly-evolving-011150649.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]